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Abstract
 
A key event in the pathogenesis of allergies is the production of antibodies of the immuno-
globulin (Ig)E class. In normal individuals the levels of IgE are tightly regulated, as illustrated by
the low serum IgE concentration. In addition, multiple immunizations are usually required to
generate detectable IgE responses in normal experimental animals. To define the parameters
that regulate IgE production in vivo, we generated mice bearing monoclonal populations of B
and T lymphocytes specific for influenza virus hemagglutinin (HA) and chicken ovalbumin
(OVA), respectively. A single immunization of the monoclonal mice with the cross-linked
OVA-HA antigen led to serum IgE levels that reached 30–200 
 
 
 
g/ml. This unusually high IgE
response was prevented by the infusion of regulatory 
 
 
 
/
 
 
 
 CD4
 
 
 
 T cells belonging to both
CD25
 
 
 
 and CD25
 
 
 
 subpopulations. The regulation by the infused T cells impeded the devel-
opment of fully competent OVA-specific effector/memory Th2 lymphocytes without inhibit-
ing the initial proliferative response of T cells or promoting activation-induced cell death. Our
results indicate that hyper IgE responses do not occur in normal individuals due to the presence
of regulatory T cells, and imply that the induction of regulatory CD4
 
 
 
 T cells could be used
for the prevention of atopy.
Key words: atopy • Th2 differentiation • immunoglobulin class switching • T lymphocytes, 
regulatory • mice, mutant strains
 
Introduction
 
High IgE antibody responses are a hallmark of atopic allergy
and asthma (1), and have been described in other human
diseases such as Omenn’s syndrome (2, 3), hyper IgE syn-
drome (4), and AIDS (5). IgE production is tightly regu-
lated, with serum concentrations about 1,000-fold lower
than any other antibody class and plasma half-life measured
in hours, not in days, as it is the case for IgG and IgM anti-
bodies (6, 7). It is therefore possible that high IgE responses
result from loss of immunoregulation (8). In fact, T lympho-
cyte abnormalities have been reported in a number of hyper
IgE conditions. Omenn’s syndrome, an immunodeficiency
caused by defective recombinase activating genes (RAG)
 
*
 
(9), is characterized by oligoclonal T lymphocyte popula-
tions with a skewed Th2 phenotype, while a decrease in
CD4
 
 
 
 cell numbers is a hallmark of AIDS.
In vivo, IgE production is strongly dependent on T/B
lymphocyte interactions (10). Studies of T cell class
switching in vitro identified two essential signals for IgE
class switching. A soluble signal is provided by the Th2 cy-
tokine IL-4. Accordingly, IL-4
 
 
 
/
 
 
 
 mice are highly defi-
cient in IgE production (11). However, IL-4
 
 
 
/
 
 
 
 mice can
produce IgE upon infection with mouse acquired immu-
nodeficiency syndrome (MAIDS) virus (12). In addition,
IL-4
 
 
 
/
 
 
 
 mice infected with 
 
Plasmodium chabaudi
 
 produced
IgE, albeit at fivefold lower levels than IL-4
 
 
 
 mice (13).
Another Th2 cytokine that is relevant for IgE production
is IL-13, whose receptor shares the IL-4R
 
 
 
 chain with the
IL-4 receptor (14). In fact, IL-13
 
 
 
/
 
 
 
 mice have been
found to have a 3–5-fold lower basal levels of IgE than
normal mice do (15).
IL-4 signaling induces germ line transcription of C
 
 
 
1
and C
 
 
 
 through the activation of signal transducer and acti-
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vator of transcription (STAT)-6, a transcription factor that
binds to cis-elements in the C
 
 
 
1 and C
 
 
 
 promoters (16).
Unlike IgE, switching to IgG1 can still be induced, albeit at
lower levels, during T cell–dependent responses in the ab-
sence of the IL-4/STAT6 pathway (17, 18).
During class switching to IgE, a second essential signal is
delivered through cognate interaction between B lympho-
cytes and Th lymphocytes and is primarily mediated by the
CD40 molecule expressed on B cells and its ligand,
CD40L, expressed on activated T cells (19–21). CD40L
and IL-4 synergize for the induction of germline C
 
 
 
1 and
C
 
 
 
 transcripts (22). Mutations that disrupt CD40 or
CD40L result in the failure of B lymphocytes to form ger-
minal centers, to undergo class switching to IgG, IgE, and
IgA, and to develop B cell memory (23–25). Both the IL-4
and CD40 mediated signals for IgE class switching can be
provided by Th2 cells, with Th1 cells being unable to pro-
vide IL-4. Thus IgE responses in vivo are dependent on the
polarization of the Th response.
Here we describe a model of immunization-induced hy-
per IgE in mice that carry monoclonal populations of T
and B lymphocytes. We demonstrate that the monoclonal-
ity of the T cell repertoire is what determines the hyper
IgE response, and that hyper IgE develops due to the ab-
sence of CD4
 
 
 
 regulatory T lymphocytes. We also show
that, in this model, regulatory T lymphocytes affect neither
the initial proliferative expansion of antigen-specific T
helper lymphocytes nor the subsequent apoptotic phase of
the T helper response. Instead, regulatory lymphocytes
block the differentiation of T helper cells into fully compe-
tent high IL-4–producing Th2 cells, causing a drastic re-
duction in class switching to IgE.
 
Materials and Methods
 
Mice.
 
The rearranged V(D)J genes of the 17/9 antibody were
cloned from the 17/9 hybridoma (26) and used to construct tar-
geting vectors for the heavy and 
 
 
 
 chain Ig loci. Targeting con-
structs containing a neo-loxP cassette were transfected into the J1
embryonic stem (ES) cell line and G418 resistant colonies carry-
ing homologous integrations were identified by Southern analy-
sis. Probes A, B, C, and D in Fig. 1 were used to characterize the
5
 
 
 
 and 3
 
 
 
 targeting sites. The neo-loxP cassette was removed by
cre-mediated recombination. Mice carrying both rearranged re-
ceptor genes were generated by crosses between single targeted
mice, and are referred to as 17/9 mice. All mice were backcrossed
onto a BALB/c background and were housed under specific
pathogen-free conditions at the Skirball Institute, New York
University School of Medicine. All 17/9 DO11.10 RAG
 
 
 
/
 
 
 
 ani-
mals in experiments that involved transfer of CD4
 
 
 
CD25
 
 
 
 sple-
nocytes (Fig. 3 B), were given sulfamethoxazole (400 mg/liter)/
trimethoprim (80 mg/liter) in the drinking water for the duration
of the experiment. This treatment prevented wasting of mice
transferred with CD4
 
 
 
CD25
 
 
 
 cells.
 
Immunizations.
 
The influenza virus hemagglutinin (HA) pep-
tide (YPYDVPDYASLRS) was synthesized by Research Genetics.
A cross-linked OVA-HA antigen was prepared by glutaraldehyde
cross-linking of the HA peptide to chicken OVA (Sigma-Aldrich).
Mice were injected by intraperitoneal route with 100 
 
 
 
g of cross-
linked OVA-HA adsorbed onto 1 mg of alum. A single immuni-
zation was performed in all experiments.
 
FACS
 
®
 
 Analysis.
 
Single cell suspensions in staining buffer
(PBS containing 2% fetal calf serum and 0.1% NaN
 
3
 
), were incu-
bated for 45 min at 4
 
 
 
C with the antibody cocktails. Samples
were analyzed in a FACSCalibur™ instrument (Becton Dickin-
son). Peanut agglutinin (PNA)-FITC and PNA-biotin were pur-
chased from Vector Laboratories. Antibodies were purchased
from BD PharMingen or Caltag. FITC-labeled and biotin-labeled
HA peptides were purchased from Research Genetics.
 
Carboxyfluorescein Diacetate Labeling, Cell Purification, and Trans-
fer.
 
Total splenocytes were labeled with carboxyfluorescein di-
acetate (CFSE; Molecular Probes) by incubating 10
 
7
 
 cells/ml in
PBS with 5 
 
 
 
M of CFSE resuspended in DMSO. Labeling was
stopped with media containing 10% fetal calf serum. Depletion
of CD4
 
 
 
, CD8
 
 
 
, B220
 
 
 
, and CD25
 
 
 
 lymphocytes, and enrich-
ment of CD25
 
 
 
 and CD4
 
 
 
 from spleen cell suspensions was per-
formed by magnetic sorting using a Miltenyi VarioMACS appa-
ratus. Cell purity was checked by FACS
 
®
 
 analysis: CD8
depletion was 
 
 
 
98% effective, whereas CD4 and B220 depletion
were both 
 
 
 
99% effective. Purified lymphocyte populations
were obtained from spleen of wild-type BALB/c mice or
BALB/c 
 
 
 
MT
 
 
 
/
 
 
 
 mice. The CD25
 
 
 
CD4
 
 
 
 purified fraction
contained no more than 3% CD4
 
 
 
CD25
 
 
 
 cells. Depletion of
CD25
 
 
 
 cells was 
 
 
 
98% effective. Cells were resuspended in PBS
and injected intravenously.
 
ELISA.
 
Total or HA-specific serum antibodies were quanti-
fied by ELISA. Purified and biotinylated antibodies to all Ig iso-
types, and standard purified immunoglobulin isotypes were pur-
chased from BD PharMingen or Caltag. Serum titer was defined
as the lowest dilution that rendered an optical density value
(OD450) higher than 0.1 after background subtraction. For the
determination of HA-specific IgE, serum samples were preincu-
bated with Gamma-bind Plus Sepharose (Amersham Pharmacia
Biotech) to remove IgG and then added to HA-coated plates. IgE
levels were subsequently determined using biotinylated anti-IgE
monoclonal antibodies. While the titer of HA-specific IgE in
17/9 DO11.10 RAG
 
 
 
/
 
 
 
 mice reached 10,000 on the third week
after immunization, IgE titers in 17/9 DO11.10 RAG
 
 
 
, 17/9
DO11.10 RAG
 
 
 
/
 
 
 
 transferred with normal splenocytes, or un-
immunized mice, were lower than 100.
 
Cytokine Production Ex Vivo.
 
Cytokine production was ana-
lyzed ex vivo by intracellular staining. Briefly, spleen cells were
stimulated with 1 
 
 
 
M OVA 323–339 peptide for 4 h or with
PMA (10 ng/ml) plus Ionomycin (500 ng/ml) for 4 h. Cytokine
secretion was subsequently inhibited by the addition of Monensin
(Sigma-Aldrich) for 2 h. Cells were then harvested, surface
stained with FITC-KJ1–26 and PerCP–anti-CD4 antibodies,
permeabilized, stained with PE-labeled anti–IL-4 and APC-
labeled anti–IFN-
 
 
 
 antibodies (BD PharMingen), and analyzed in
a FACSCalibur™ (Becton Dickinson).
 
Online Supplemental Materials.
 
Supplemental figures can be
accessed at http://www.jem.org/cgi/content/full/194/9/1349/
DC1. The supplementary data section includes the analysis of all
immunoglobulin isotypes after immunization, the regulation of
IgG1 production, and a comparative analysis of T and B cell acti-
vation in spleen and LNs.
 
Results
 
A Mouse Model of Hyper IgE.
 
To monitor the induction
and regulation of the IgE response we used mice that pro- 
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duce a high frequency of T and B lymphocytes specific for
defined antigens. A new mouse strain which carries V(D)J
replacements for the heavy and light chain genes of the
monoclonal antibody 17/9 was generated by gene targeting
(Fig. 1). This mouse strain, referred to as 17/9, harbors a
large number of mature B lymphocytes specific for HA of
the influenza virus. 17/9 DO11.10 RAG
 
 
 
/
 
 
 
 mice were
generated by crossing the 17/9 mice with the DO11.10
anti-OVA T cell receptor transgenic mice (27), and subse-
quently incorporating a RAG1 null mutation (28). 17/9
DO11.10 RAG
 
 
 
/
 
 
 
 mice produce monoclonal populations
of anti-HA B lymphocytes and anti-OVA CD4
 
 
 
 T lym-
phocytes. In contrast, 17/9 DO11.10 RAG
 
 
 
 mice harbor,
in addition to the HA and OVA-specific lymphocytes,
other B and T lymphocytes expressing antigen receptors
encoded by the endogenous loci (Fig. 2 A). Immunization
of the 17/9 DO11.10 RAG
 
 
 
/
 
 
 
 and 17/9 DO11.10 RAG
 
 
 
mice with a cross-linked OVA-HA antigen induced a T
cell–dependent antibody response in both groups of mice.
However, the outcome of the immunization was very dif-
ferent in both groups, resulting in a two order of magni-
tude increase in total IgE levels in the 17/9 DO11.10
RAG
 
 
 
/
 
 
 
 but not in the 17/9 DO11.10 RAG
 
 
 
 mice (Fig.
2 B). The possibility that the observed differences reflected
an impaired clearance of serum Igs in the RAG
 
 
 
/
 
 
 
 strain
rather than increased class switching was ruled out by the
measurement of Ig half-life (online supplemental Figure
S1). The production of HA-specific antibodies of all IgG
isotypes was stimulated in mice of both strains by the im-
munization (online supplemental Figure S2). However, se-
rum titers for HA-specific IgGs were higher in the 17/9
DO11.10 RAG
 
 
 
/
 
 
 
 strain than in the RAG
 
 
 
 strain. Among
HA-specific IgGs, the largest difference was in IgG1, which
reached titers 
 
 
 
20 fold higher in 17/9 DO11.10 RAG
 
 
 
/
 
 
 
mice than in their RAG
 
 
 
 littermates (Fig. 2 C).
 
Monoclonality of the T Cell Compartment Determines the Hy-
per IgE Response.
 
The unusually high levels of IgE dis-
played by 17/9 DO11.10 RAG
 
 
 
/
 
 
 
 mice suggested that
these mice lack a normal mechanism for the downregula-
tion of IgE responses. As 17/9 DO11.10 RAG
 
 
 
 mice,
which do not develop hyper IgE, harbor both T and B cells
expressing endogenous receptors, it was possible that either
one or both of these lymphocyte populations were impor-
tant to prevent hyper IgE responses.
We investigated the role of T cells expressing endoge-
nous receptors by using an adoptive transfer system. HA-
specific monoclonal B cells from 17/9 RAG
 
 
 
/
 
 
 
 mice,
which lack T cells, were transferred into two groups of B
cell-deficient recipients, DO11.10 RAG
 
 
 
/
 
 
 
 mice and
DO11.10 
 
 
 
MT
 
 
 
/
 
 
 
 mice. DO11.10 RAG
 
 
 
/
 
 
 
 mice gener-
ate exclusively OVA-specific T cells, whereas DO11.10
 
 
 
MT /  mice generate both OVA-specific T cells and
other T cells expressing endogenous T cell receptors.
Transfers of HA-specific B cells were performed on day 3
postimmunization to ensure that the initial T helper cell
activation occurred in the absence of any B cells. Mono-
clonal HA-specific B cells were also transferred into immu-
nized DO11.10 RAG  MT  mice to determine the effect
of normal B cells on the IgE response. Fig. 2 D shows that
only DO11.10 RAG /  recipient mice developed hyper
IgE, whereas IgE levels were 70- and 200-fold lower in
DO11.10  MT /  and DO11.10 RAG  MT  mice re-
Figure 1. Generation of 17/9 homologous replacement mice.
(A and B) Schematic representation of the targeting of the 17/9
antibody genes into A: the heavy chain, and B: the   light chain
immunoglobulin loci. 1: germline loci; 2: targeting vectors; 3: tar-
geted loci. J genes (JH and J ),   switch region (S ),   enhancer
(E ), and   and   constant regions (C  and C , respectively) are
indicated. Neo-loxP indicates the lox-P flanked neomycin resis-
tance cassette. Restriction sites: B, BamHI; C, Cla I; E, EcoRI; H,
HindIII; M, MfeI; S, SmaI; X, XhoI. (C) Southern analysis of Mfe
I-digested DNA from 17/9 VDJ heavy chain gene targeted ES
clones before (R11 clone) and after (F3 and A9 clones) cre-medi-
ated deletion of the neo-loxP cassette. The filter was hybridized to probe A in panel A. DNA from the untargeted J1 ES cell line is also shown. (D)
Southern analysis of VJ 17/9   light chain targeted ES clones. BamHI/EcoRI double-digested DNA was hybridized to probe D in B. Targeted clones
before (V11) and after (B1) deletion of the neo-loxP cassette. J1: untargeted ES cell line.1352 Regulatory T Cells Prevent Hyper IgE Responses
spectively. These results demonstrate that the repertoire of
the T cell compartment has the major effect on the magni-
tude of the IgE response.
It has been shown that optimal levels of T cell priming
by antigen-presenting B cells require the involvement of
antigen-specific B cells (29). B cell receptor–mediated up-
take of antigen leads to a rapid upregulation of the expres-
sion of B7–2, thereby enhancing T cell stimulation (30).
Although the monoclonality of the T cell compartment de-
termined the hyper IgE response, it is, however, likely that
the high number of HA-specific B cells contributed to the
stimulation of OVA-specific T cells induced by immuniza-
tion with the cross-linked OVA-HA antigen.
CD4   /  T Cells Downregulate the IgE Response. We
subsequently tested whether lymphocytes from normal do-
nors would also display regulatory activity upon transfer
into 17/9 DO11.10 RAG /  recipients. In this experi-
ment, the responding OVA-specific T cells are identical in
both transferred and nontransferred experimental groups.
As the OVA-specific T cell populations of 17/9 DO11.10
RAG /  and 17/9 DO11.10 RAG  mice may differ in
number and/or TCR expression levels, the use of the
transfer system overcame this potential problem. Total
spleen cells from wild-type mice, TCR   /  mice (which
lack mature  /  T cells [31]), or normal splenocytes de-
pleted of CD4 , CD8 , or B220  lymphocytes, were
transferred into 17/9 DO11.10 RAG /  mice 24 h before
immunization. The analysis of the IgE response showed
that the regulatory activity of normal splenocytes is absent
in TCR   /  spleen cells and in CD4  T cell–depleted
normal spleen cells (Fig. 3 A). Thus, CD4   /  T cells are
essential for the control of hyper IgE by normal spleno-
cytes. Neither CD8  T cells nor B cells were necessary for
this regulation. Furthermore, by transferring cells from
BALB/c IFN-  /  and BALB/c IL-4 /  mice, we were
able to establish that the downregulation of the IgE re-
sponse was only marginally dependent on IFN-  and was
independent of IL-4 (online supplemental Figure S3 c).
A subpopulation of CD4  T cells which expresses
CD25 (the   chain of the IL-2 receptor) displays downreg-
ulatory activity in some autoimmune diseases and tu-
mor rejection responses (32–34). To investigate whether
Figure 2. Hyper IgE production
in mice with monoclonal popula-
tions of B and T lymphocytes. (A)
HA-specific B cells and OVA-spe-
cific (KJ1–26 ) T cells in 17/9
DO11.10 RAG /  mice (plots on
left) and 17/9 DO11.10 RAG 
mice (plots on right). FACS® analy-
sis of peripheral blood lymphocytes
from 4-wk-old mice. Only 10% of
the CD3  KJ1–26  T cells are
CD8 , comprising less than 2% of
the FSC   SSC lymphocyte gate.
(B) Total serum IgE levels 14 d after
single immunization. n   7 mice per
group. (C) Ratios of HA-specific se-
rum immunoglobulin titers in sera of
17/9 DO11.10 RAG /  and 17/9
DO11.10 RAG  mice 14 d after
single immunization. n   7 mice per
group. (D) T cells determine the hy-
per IgE phenotype. 5   106 spleen
cells from 17/9 RAG /  mice (con-
taining monoclonal anti-HA B cells)
were transferred into DO11.10
RAG /  mice (left bar), DO11.10  MT /  mice (middle bar), and DO11.10 RAG  MT  mice (right bar) 3 d after single immunization. The graphic
shows total IgE levels in sera of mice on day 14 after immunization. n   3 to 4 mice per group.1353 Curotto de Lafaille et al.
CD4 CD25  T lymphocytes could reduce the hyper IgE
response, splenocytes were harvested from wild-type
BALB/c mice or BALB/c  MT /  mice, and separated
into fractions containing CD4 CD25  T cells, CD4 
CD25  T cells, or total CD4  T cells. Spleen cell fractions
containing equal numbers of CD4  T cells were then
transferred into 17/9 DO11.10 RAG /  recipients one
day before immunization. The results of three experiments
(Fig. 3 B) demonstrated that the transfer of total CD4 ,
CD4 CD25 , or CD4 CD25  spleen populations pre-
vented the development of hyper IgE in 17/9 DO11.10
RAG /  recipient mice. Although there was some varia-
tion in IgE levels between experiments, it is clear that both
CD4 CD25  and CD4 CD25  splenic populations con-
tain T lymphocytes capable of downregulating the HA-
specific IgE response following similar dose–response
curves (Fig. 3 B).
In all experiments described, HA-specific IgG1 serum
levels were analyzed and found to be regulated in the same
way as IgE, however, the extent of IgG1 downregulation
was less marked than the IgE downregulation found in the
same mice (online supplemental Figure S3).
Regulation by T Cells Does Not Inhibit Early Antigen-specific
T Cell Activation. Our next experiments aimed to deter-
mine which phase of the immune response was affected by
regulatory lymphocytes. As T cells determine the hyper
IgE phenotype (Figs. 2 and 3), and T cell activation pre-
cedes B cell activation in T cell–dependent responses (35,
36), we hypothesized that regulation would primarily affect
the responding T helper lymphocytes. In T cell–dependent
responses antigen-specific T lymphocytes undergo an initial
proliferative burst that is followed by a dramatic decrease in
cell numbers believed to represent activation-induced T
cell death (AICD). Some T cells emerging from this initial
burst migrate to the follicles, participate in the germinal
center reaction, and develop into memory cells (35). We
wished to determine whether the mechanism of action of
regulatory lymphocytes involved the inhibition of the ini-
tial proliferative phase of the T helper response, the stimu-
lation of the apoptotic phase of the Th response, and/or an
impaired generation of effector/memory Th2 lymphocytes.
Early T cell activation and proliferation was assessed by
the counting of OVA-specific T cells, the determination of
cell size, the expression of early activation markers such as
Figure 3. Development of hyper IgE can
be prevented by normal TCR  /  CD4 
splenocytes. (A) Total (2.5   107) or frac-
tionated spleen cells (CD4-depleted, CD8-
depleted, B220-depleted: 2   107) from
wild-type BALB/c mice or total spleen cells
from TCR   /  mice (2   107) were trans-
ferred into 17/9 DO11.10 RAG /  recipi-
ents 1 d before immunization. Total IgE se-
rum levels were determined 14 d after
immunization. n   6–8 mice per group. (B)
Purified spleen cells populations obtained
from wild-type BALB/c mice or BALB/c
 MT /  mice were transferred to 17/9
DO11.10 RAG /  recipients one day be-
fore immunization. Serum IgE levels were
determined 19 d after immunization. Exp 1:
three cell populations were obtained from
wild-type BALB/c donors and transferred:
(1) purified CD4 CD25  spleen cells (6  
105); (2) spleen cells depleted of B220 ,
CD8 , and CD25  lymphocytes (6   105
or 3   106 CD4 CD25  cells transferred);
(3) spleen cells depleted of B220  and CD8 
lymphocytes (6   105 or 3   106 total
CD4  T cells transferred). Exp 2: purified
CD4 CD25  spleen cells, and spleen cells
depleted of CD25  cells were obtained from
BALB/c  MT /  donors and transferred in
doses of 5   105 or 105 CD4  T cells. Exp
3: CD4 CD25  and CD4 CD25  donor
spleen cells were obtained from BALB/c
 MT /  donors. To purify CD4 CD25 
cells, spleen cells were first depleted of
CD25  cells. Subsequently, CD4  cells
were positively sorted. (C) Typical FACS®
profiles of purified donor populations are
shown. Dot plots contain the profiles of cells
in a broad FSC/SSC lymphocyte gate. The
three plots on the left show donor cells from
Exp 2. The plot on the right shows purified
CD4 CD25  cells from Exp 3.1354 Regulatory T Cells Prevent Hyper IgE Responses
CD25 and CD69, and the rate of cell division. Fig. 4 A
shows a kinetic analysis of the numbers of splenic OVA-
specific (KJ1–26 CD4 ) T cells in immunized 17/9
DO11.10 RAG /  mice, 17/9 DO11.10 RAG  and 17/9
DO11.10 RAG /  mice transferred with normal spleno-
cytes (cell numbers of unimmunized mice shown at time
point zero). Expansion of the anti-OVA T cells was similar
in the three groups, with cell numbers peaking around days
2 and 3 d after immunization and declining thereafter.
Likewise, the kinetics of upregulation and downregulation
of CD25 and CD69 expression in spleen cells from 17/9
DO11.10 RAG /  mice and 17/9 DO11.10 RAG / 
mice transferred with normal splenocytes showed no differ-
ences. Most OVA-specific T cells upregulated CD25 and
CD69 expression levels at 15 h after immunization in both
groups (Fig. 4 B, and online supplemental Figure S4). Sim-
ilar kinetics of expansion/contraction in the number of
OVA-specific T cells and expression of activation markers
were observed after analysis of lymph node cells (online
supplemental Figure S5).
The analysis of cell division profiles of a trace population
of CFSE-labeled OVA-specific T cells also did not reveal
differences between 17/9 DO11.10 RAG /  mice and 17/9
DO11.10 RAG /  mice transferred with normal spleno-
cytes (Fig. 4 C). Interestingly, the proportion of cells in the
high CFSE peaks (low cell division number) increased
from the 3rd to the 5th day after immunization suggesting
that T cell death in the low CFSE (high cell division) peaks
was taking place. As the transferred OVA-specific T cells
could not be distinguished from the endogenous ones after
they became CFSE negative, differences due to a small
population of dividing cells at later time points could not
be determined.
These results demonstrate that a massive activation of
OVA-specific T cells takes place in mice that develop hy-
per IgE as well as in mice that efficiently control this re-
sponse, indicating that the hyper IgE phenotype is not due
to large differences in the magnitude of the initial T helper
response. The fact that expansion was followed by a con-
traction of the antigen-specific T cell population in all im-
munized groups indicates in addition that the hyper IgE
phenotype is not caused by a defect in AICD in the 17/9
DO11.10 RAG /  mice.
Regulatory Cells Inhibit the Differentiation of Th2 Lympho-
cytes. We next investigated whether the formation of ef-
fector/memory T helper cells was affected by regulatory
lymphocytes. As effector/memory T helper cells are char-
acterized by a fast and intense production of cytokines after
stimulation (37), we analyzed the production of IL-4 and
IFN-  by OVA-specific T cells from immunized 17/9
DO11.10 mice ex vivo by intracellular staining. As shown
in Fig. 5 A, IL-4 IFN-   T cells were virtually undetect-
able in 17/9 DO11.10 RAG /  unimmunized mice, were
present in low numbers 3 d after immunization and
Figure 4. Analysis of activation of OVA-specific T cells. (A) Variation in KJ1–26 CD4  lympho-
cyte number in spleens of 17/9 DO11.10 immunized mice. Mean and SD of groups of three mice per
time-point are shown. Filled diamonds: 17/9 DO11.10 RAG /  mice; filled triangles: 17/9 DO11.10
RAG /  mice transferred with 2   107 normal splenocytes; filled squares: 17/9 DO11.10 RAG 
mice. (B) CD25 expression in KJ1–26 CD4  lymphocytes is not affected by regulatory lymphocytes.
FACS® histogram profiles of KJ1–26 CD4  gated spleen cells from 17/9 DO11.10 RAG /  mice (No
transfer) and 17/9 DO11.10 RAG /  mice that were transferred with 2   107 normal spleen cells one
day before immunization (Tr. Normal Spl.). (C) Analysis of cell division of OVA-specific CD4  lym-
phocytes. Spleen cells from DO11.10 RAG /  mice (which contain monoclonal anti-OVA T cells)
were labeled with CFSE and transferred (106 OVA-specific T cells) alone or together with unlabeled
2   107 normal splenocytes, into 17/9 DO11.10 RAG /  mice. Recipient mice were immunized 1 d
after transfer. Cell division of transferred cells in the spleen was analyzed at several times after immuni-
zation. The top three panels illustrate the gating of KJ1–26 CD4 CFSE  cells and the determination of
CFSE intensity intervals defined by CFSE fluorescence peaks (1 to 6, with peak 6 representing T cells
that did not divide). The bottom three panels show the distribution of KJ1–26 CD4  CFSE  cells (as
percentage of total KJ1–26 CD4  CFSE ) into CFSE fluorescence intervals (numbers 1 to 6 in top
panel). Filled diamonds: 17/9 DO11.10 RAG /  mice; filled triangles: 17/9 DO11.10 RAG /  mice
transferred with 2   107 normal splenocytes.1355 Curotto de Lafaille et al.
reached up to 10% of the OVA-specific (KJ1–26 ) CD4 
splenic cells by day 10 after immunization. IFN-  IL-4 
cells also increased but to a lesser degree (Fig. 5 A). Strik-
ingly, cells from 17/9 DO11.10 RAG /  mice transferred
with normal splenocytes never developed into high cyto-
kine producers, indicating that the mechanism of regulation
does not involve immune deviation to a Th1 phenotype.
The intracellular staining data was confirmed by ELISA as
well as quantitative competitive RT-PCR (online supple-
mental Figure S6).
The production of IL-4 and IFN-  by donor-derived T
cells in 17/9 DO11.10 RAG /  mice transferred with
wild-type splenocytes was analyzed by intracellular stain-
ing. The percentage of IL-4 IFN-   cells in the KJ1–26 
T cell population was below 0.5% at all time points ana-
lyzed (days 3, 6, and 10 after immunization), whereas the
percentage of IFN-  IL-4  cells in the same population
was below 1.1%. The frequency of IL-4 IFN-   double
positive cells was always below 0.1% (online supplemental
Figure S7).
The large increase in the production of cytokines, par-
ticularly IL-4, by OVA-specific T cells from 17/9
DO11.10 RAG /  mice took place after the initial prolif-
erative-apoptotic phases of the response, and coincided
with the appearance of substantial numbers of OVA-spe-
cific T cells expressing high levels of the surface molecule
CD44 and low levels of CD45RB (Fig. 5 B). Upregula-
tion of CD44 and downregulation of CD45RB have been
described in cells with effector/memory phenotype (37).
Another example documenting that differentiation to high
cytokine-producing cells is related to changes in T cell
marker expression has been shown for CD45RB (38). Ac-
cordingly, the CD44hiCD45RBlo population was consid-
erably reduced in 17/9 DO11.10 RAG /  mice trans-
ferred with normal splenocytes (Fig. 5 B). Taken together,
the results of the experiments shown in Fig. 5 demonstrate
that the differentiation of effector/memory T helper lym-
phocytes is greatly impaired in the presence of regulatory
T lymphocytes.
Regulatory Cells Inhibit Germinal Center Formation. A
substantial proportion of T cell–dependent Ig class switch-
ing occurs in specialized lymphoid follicles named germinal
centers (39, 40). To monitor germinal center formation,
we stained spleen cells with PNA, a lectin that binds to B
cells located exclusively in germinal centers (41). Fig. 5 C
shows that while the presence of PNA  B lymphocytes was
evident in 17/9 DO11.10 RAG /  mice 10 d after immu-
nization, the number of PNA  B cells in 17/9 DO11.10
RAG /  mice transferred with normal splenocytes was sig-
nificantly lower. The reduction in germinal center forma-
tion was probably secondary to the inhibition of Th2 dif-
ferentiation, as it has been shown that Th2 cells are
necessary to mediate the germinal center reaction (42).
Discussion
We described here that mice displaying a monoclonal T
and B cell repertoire developed a very high antigen-specific
IgE response, with serum levels in the range of 30–200  g/
ml upon a single immunization with the cognate antigen.
In this model, the genetic background of the mice, as well
Figure 5. Effector/memory Th2 development and germinal center for-
mation are inhibited by regulatory lymphocytes. (A) Cytokine production
by OVA-specific T cells after immunization. Spleen cells from 17/9
DO11.10 RAG /  immunized mice (No transfer) or 17/9 DO11.10
RAG /  mice that were transferred with 2   107 normal spleen cells one
day before immunization (Tr. Normal Spl.) were analyzed for the pro-
duction of IL-4 and IFN-  by intracellular staining. Cells were stimu-
lated in vitro with OVA peptide and processed as described in Materials
and Methods. The graphic shows anti–IL-4 and anti–IFN-  plots of
KJ1–26 CD4  gated spleen cells. Unimmunized mice display less than
0.1% of KJ1–26 CD4  positive cells with either anti–IL-4 or anti–IFN- 
antibodies and no detectable population of IL-4 IFN-   double-positive
cells. (B) CD44/CD45RB staining of KJ1–26 CD4  gated spleen cells
from 17/9 DO11.10 RAG /  immunized mice (No transfer) or 17/9
DO11.10 RAG /  mice that were transferred with 2   107 normal spleen
cells one day before immunization (Tr. Normal Spl.). Unimmunized con-
trols analyzed simultaneously as day 14 samples are also shown. (C) De-
creased number of PNA  cells in 17/9D011.10 RAG /  mice transferred
with normal splenocytes. PNA/HA staining is shown for B220  gated
splenocytes from 17/9 DO11.10 RAG /  mice (No transfer) and from
17/9 DO11.10 RAG /  mice that were transferred with 2   107 normal
spleen cells (Tr. Normal Spl.). Unimmunized controls analyzed simulta-
neously with the 10-d immunization samples are also shown. As expected,
germinal center B cells showed downregulation of the B cell receptor.1356 Regulatory T Cells Prevent Hyper IgE Responses
as the adjuvant and route of immunization favored the dif-
ferentiation of Th2 cells. In addition, the genetic ablation
of regulatory T cells in the 17/9 DO11.10 RAG /  mice
provided an unobstructed environment for T helper cell
differentiation to occur. Cognate help from differentiated
Th2 cells in turn allows a high rate of B lymphocyte class
switching to IgE. We also showed here that regulation by
T cells affects the development of fully competent effector/
memory Th2 lymphocytes without inhibiting the initial
proliferative response of T cells and without acceleration of
activation-induced cell death.
It has been amply documented that antigen-specific IgE
responses can be downregulated by transfer of T cells (43–
48). The main difference between our data and the previ-
ously published data is that in all of the referred manu-
scripts, antigen priming of the donor animals (or cells) was
absolutely essential for the downregulation of IgE response,
whereas in our case highly effective downregulation of IgE
response was attained by T cells obtained from unimmu-
nized wild-type donors. This discrepancy probably reflects
the different phases of the T cell–dependent B cell response
at which the different types of regulatory cells act. The reg-
ulatory activity that we described here displays its effect rel-
atively early in the response, by drastically impairing helper
T cell differentiation. This type of regulation was present in
the recipients of antigen-primed regulatory T cells de-
scribed by the other authors, since the recipient mice had a
normal CD4  compartment. Thus, no additional regula-
tion (no effect on the IgE response) was observed when
unprimed T cells were transferred. Different aspects of a
multilayer T cell regulation of IgE responses are, therefore,
uncovered in different experimental models. In 17/9
DO11.10 RAG /  mice, there are no regulatory T cells of
any kind, and this is likely the reason why the IgE response
reaches hyper IgE levels after a single immunization.
Our results clearly show that regulatory T cells do not
prevent hyper IgE production by inducing immune devia-
tion of the naive OVA-specific T cells to a Th1 phenotype,
as OVA-specific T cells in mice transferred with wild-type
splenocytes did not become IFN-  producers. Moreover,
both Th1 and Th2 responses were decreased by the infused
regulatory cells (Fig. 5). In view of the abundance of data
indicating the role of TGF-  (49–55) and IL-10 (48, 56–
61) in the control of both Th1 and Th2 responses, it is
likely that these cytokines are also involved in the downreg-
ulation of hyper IgE responses in our experimental system.
We described in this manuscript that regulatory  / 
CD4  T cells displaying both CD25  and CD25  pheno-
type can prevent the hyper IgE response upon transfer into
17/9 DO11.10 RAG /  mice. A population of T cells
which coexpresses CD4 and CD25 has been shown to pre-
vent the development of several autoimmune diseases and
inflammatory bowel disease (IBD) (32, 33, 58, 62, 63).
While the CD4 CD25  population was initially consid-
ered to be devoid of regulatory cells, more recent work has
challenged this perception. Thus, it was mentioned that
CD25  T cells confer protection against experimental au-
toimmune encephalomyelitis (EAE) (64), and it was shown
that CD4 CD25  T cells can prevent diabetes (34) and
IBD (58).
In our hyper IgE model, CD25  T cells were clearly
protective. To assess the regulatory potential of CD25  T
cells, recipient mice were kept under wide spectrum anti-
bacterial/antifungal prophylaxis to prevent wasting disease.
Under these conditions, both CD25  and CD25  T cells
effected similar regulatory activity on the hyper IgE re-
sponse. The downregulation of the IgE response by total
splenocytes is, therefore, the result of combined effects of
the CD25  and CD25  regulatory T cells. The differences
between experimental systems may be explained in the fol-
lowing way. The CD4 CD25  population contains Th
precursors which are effective in causing IBD and related
inflammatory diseases without the need for immunization,
but does not contain a sizable number of OVA-specific Th
cell precursors capable of driving a hyper IgE response
upon a single immunization of the recipient mice. Thus,
the contribution of the CD4 CD25  donor-derived pop-
ulation to the B cell help is minimal in comparison to the
large number of OVA-specific T cells present in 17/9
DO11.10 RAG /  mice. In situations where the CD25 
cells do not play a major effector role, such as in the 17/9
DO11.10 RAG /  mice, the regulatory capacity of the
CD4 CD25  population can be easily appreciated. A simi-
lar argument can be put forward to explain the protective
effect of CD4 CD25  T cells in a TCR transgenic model
of spontaneous EAE (64). Moreover, in the other publica-
tions in which CD4 CD25  T cells were shown to display
regulatory activity, the number of effector cell precursors
present in the CD25  population was reduced either by
depletion of recent thymic emigrants (34) or by using
CD4 CD25  cells from the CD45RBlo population (58).
The antigen specificity of the regulatory T cells that pre-
vent hyper IgE responses remains a major unresolved issue.
The relationship between the regulatory T cells which pre-
vent hyper IgE and the regulatory T cells which prevent
autoimmune diseases and graft rejection is also unclear.
There are, however, remarkable similarities between the
hyper IgE system described here and the spontaneous au-
toimmunity system that we described some years ago (65).
In the latter system, autoimmune encephalomyelitis devel-
ops spontaneously in mice harboring a monoclonal self-
specific T cell repertoire (TCR transgenic RAG / ), but
not in TCR transgenic RAG  mice. In addition, a small
number of polyclonal CD4  T cells (both CD25  or
CD25 ) can suppress the development of spontaneous dis-
ease (64–66). There are also important differences, such as
the need for immunization in order to obtain a hyper IgE
response, the genetic background (C57BL versus BALB/c),
and the nature of the response (Th1 in EAE and Th2 in the
hyper IgE).
Hyper IgE is often associated with human immunodefi-
ciencies such as the hyper IgE syndrome (4), Omenn’s syn-
drome (3), and AIDS (5). Abnormalities in the T cell com-
partment have been described in all these diseases. Given
the data shown herein, it is possible that the hyper IgE ob-
served in patients afflicted with these immunodeficiencies is1357 Curotto de Lafaille et al.
caused by a marked deficiency in the regulatory T cell
compartment. Similarly, high and sustained IgE responses
have been observed in rats immunized after sublethal irra-
diation, treatment which causes a temporary lymphopenia
(67). Our results may also help explain why the levels of
autoantibodies belonging to T cell–dependent classes, in
particular IgG1 and IgE, are increased in TCR   /  mice
(68). While some T helper functions in these mice can be
performed by  /  T cells (69) or CD4  T cells expressing
the TCR   chain (70), regulatory T cells appear to be
strictly  /  T cells and are thus absent in TCR   /  mice.
Atopy is a human condition of multigenic origin which
is characterized by the predisposition to produce IgE
against environmental, noninfectious antigens. The MHC,
the IL-4/IL-13/IL-5/IL-9 cytokine cluster, IL-4 receptor,
and the Fc RI-  chain have all been implicated in the sus-
ceptibility to atopy and asthma in a variety of human or
mouse studies (71). Based upon our results, we speculate
that another group of susceptibility genes, perhaps shared
between individuals afflicted with atopic or autoimmune
diseases, may affect the downregulation of immune re-
sponses mediated by regulatory T cells. Interestingly, a
negative correlation between atopic condition and the inci-
dence/severity of certain cancers has been reported (72–
75). As the experimental depletion of CD25  regulatory T
cells in mice inoculated with syngeneic tumors leads to in-
creased killer activity, decreased tumor size and reduced
cancer-related death (76, 77), it is possible that the level of
regulatory T cell activity of each individual is one of the
determinants of the ease in which T helper–dependent re-
sponses occur. Low regulatory T cell activity may therefore
result in exaggerated T helper differentiation during re-
sponses to self or environmental antigens, leading to au-
toimmune disease or atopy.
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